Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome ...
Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...
The workflow of metabolomics can be divided into four parts: (1) sample collection and preparation; (2) metabolic profiling; (3) data processing and analysis; and (4) pathway analysis (created by ...
This article and associated images are based on a poster originally authored by Paulina Chorobik, Maciej B. Olszewski, John Vincent and Kirsty Winn and presented at ELRIG Drug Discovery 2025 in ...
In 2025, Generative AI will prove transformational for drug discovery in the healthcare industry. With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the ...
News-Medical.Net on MSN
Artificial intelligence unlocks new frontiers in RNA drug design
In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback